Senores Pharmaceuticals Limited has submitted a regulatory intimation to BSE Limited and National Stock Exchange of India Limited regarding a management change.
The disclosure confirms that Mr. Vinay Kumar Mishra, Company Secretary and Compliance Officer, will be relieved from his duties and responsibilities with effect from the closure of business hours on June 10, 2026. This follows an earlier intimation regarding his resignation dated May 14, 2026.
In accordance with Regulation 30(5) of the SEBI Listing Regulations, the company has authorized the following Key Managerial Personnel to determine materiality of events and make disclosures to stock exchanges:
- Mr. Swapnil Jatinbhai Shah, Managing Director
- Mr. Deval Rajnikant Shah, Whole Time Director and Chief Financial Officer
The company noted that all requisite information required under SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 had already been provided with the earlier intimation dated May 14, 2026, along with a copy of the resignation letter.
The document is signed by Deval Rajnikant Shah, Whole Time Director & CFO (DIN: 00332722), and includes the company's registered office address and contact information.